References
- Butler R, Carney S, Cipriani A et al. Depressive disorders. In: Clinical Evidence Concise 13. BMJ Publishing Group, London, UK, 291–297 (2005).
- Parker G. Critique of the guidelines for the treatment of depression: flaws in the construction. Aust. NZ. J. Psych. 38, 885–890 (2004).
- TenHave TR, Coyne J, Salzer M, Katz I. Research to improve the quality of care for depression: alternatives to the simple randomized clinical trial. Gen. Hosp. Psych. 25, 115–123 (2003).
- Westen D, Novotny CM, Thompson-Brenner H. The empirical status of empirically supported psychotherapies: assumptions, findings and reporting in controlled clinical trials. Psychol. Bull.130, 631–663 (2004).
- Kaplan A. Recruiting volunteers for clinical drug trials. Psychiatric Times. XV(5), (1998).
- Haberfellner EM. Recruitment of depressive patients for a controlled clinical trial in a psychiatric practice. Pharmacopsychiatry 33(4), 142–4 (2000).
- Schlernitzauer M. Bierhals AJ. Geary MD et al. Recruitment methods for intervention research in bereavement-related depression. Five years' experience. Am. J. Geriatric. Psych. 6(1), 67–74 (1998).
- Lenzen MJ, Boersma E, Scholte OP et al. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. Eur. Heart. J. (2005). (In Press).
- Barbui C, Hotopf M. Forty years of antidepressant drug trials. Acta. Psychiatr. Scand. 104, 92–95 (2001).
- Worrall J. What evidence in evidence-based medicine? Philos. Sci. 69, 316–331. (2002).
- King M, Nazareth I, Lampe F et al. Impact of participant and physician intervention preferences on randomized trials. JAMA 293(9), 1089–1099 (2005).
- Gotay CC. Accrual to cancer clinical trials: directions from the research literature. Soc. Sci. Med. 33, 569–577 (1991).
- Fairhurst K, Dowrick C. Problems with recruitment in a randomized controlled trial of counselling in general practice: causes and implications. J. Health. Serv. Res. Policy. 1, 77–80 (1996).
- Charney DS, Nemeroff CB, Lewis L et al. National Depressive and Manic Depressive Association Consensus Statement on the use of placebo in clinical trials of mood disorders. Arch. Gen. Psych. 59, 262–270 (2002).
- Kirsch I, Weixel LJ. Double-blind versus deceptive administration of a placebo. Behav. Neuro. 102(2) 319–323 (1988).
- Hotopf M, Lewis G, Normand C. Putting trials on trial – the costs and consequences of small trials in depression: a systematic review of methodology. J. Epidemiol. Comm. Health. 51(4), 354–358 (1997).
- Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Lancet. 357, 1191–1194 (2001).
- Streiner DL. The 2 “Es” of research: Efficacy and Effectiveness. Can. J. Psych. 47(6), 552–556 (2002).
- Zelen M. A new design for randomized clinical trials. N. Eng. J. Med. 300, 1242–1245 (1979).
- Quilty B. Tucker M. Campbell R. Dieppe P. Physiotherapy, including quadriceps exercises and patellar taping, for knee osteoarthritis with predominant patello-femoral joint involvement: randomized controlled trial. J. Rheum. 30(6), 1311–1317, (2003).
- Gilbody S, Whitty P. Improving the delivery and organisation of mental health services: beyond the conventional randomized controlled trial. Br. J. Psych. 180, 13–18 (2002).
- Hafkenscheid A. Psychometric measures of individual change: an empirical comparison with brief psychiatric rating scale (BPRS). Acta. Pschiatr. Scand. 101, 235–242 (2000).
- Bower P, Rowland N, Hardy R. The clinical effectiveness of counselling in primary care: a systematic review and meta-analysis. Psychol. Med. 33, 203–215 (2003).
- Simpson S, Corney R, Fitzgerald P, Beecham J. A randomized controlled trial to evaluate the effectiveness and cost-effectiveness of psychodynamic counselling for general practice patients with chronic depression. Psychol. Med. 33, 229–239 (2003).